课题基金 / 基金详情

项目摘要

项目成果

ALAN D FRANKEL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Tat is an unusual transcriptional activator that operates by binding to an RNA site (TAR) and enhancing elongation from the viral LTR. Tat and TAR form a larger complex with the cellular elongation factor P-TEFb, composed of cyclin T1 (CycT1) and Cdk9 subunits. Tat also interacts with other proteins of the transcriptional machinery. P-TEFb exists in two complexes in cells. In the small complex (SC), which consists of CycT1 and Cdk9, the kinase is active and phosphorylates the C-terminal domain (CTD) of RNA Pol II, leading to increased processivity. In the large comlex (LC), which consists of the HEXIM1 protein and 7SK snRNA in addition to P-TEFb, the kinase is inactive. Tat can displace HEXIM1 from 7SK snRNA and recruit the now active P-TEFb to the HIV LTR. To date, the NMR structures of only the Tat arginine-rich motif (ARM) peptide-TAR RNA and argininamide-TAR binary complexes have been solved. Studies of Tat in the HARC Center aim to determine the structures of Tat-P-TEFb-TAR complexes, as well as those of a minimal Tat-CycT1 chimera bound to TAR and of the LC. These structures will be compared to those of Tat- TAR complexes to ascertain similarities and differences in the binding surfaces and bound conformations and in order to better understand the postulated roles of induced fit in Tat function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2
Project 2
HIV-HOST PROTEIN COMPLEXES
HIV-HOST PROTEIN COMPLEXES
国内基金
海外基金
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2019
  • 负责人:
    辛贵忠
  • 依托单位: